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Objective: This study was undertaken to determine the prevalence, characteristics, risk factors, and temporal profile
of concurrent ischemic lesions in patients with acute primary intracerebral hemorrhage (ICH).
Methods: Patients were recruited within a prospective, longitudinal, magnetic resonance imaging (MRI)-based study
of primary ICH. Clinical, demographic, and MRI data were collected on all subjects at baseline and 1 month.
Results: Of the 138 patients enrolled, mean age was 59 years, 54% were male, 73% were black, and 84% had a history
of hypertension. At baseline, ischemic lesions on diffusion-weighted imaging (DWI) were found in 35% of patients. At 1
month, lesions were present in 27%, and of these lesions, 83% were new and not present at baseline. ICH volume (p ¼
0.025), intraventricular hemorrhage (p ¼ 0.019), presence of microbleeds (p ¼ 0.024), and large, early reductions in
mean arterial pressure (p ¼ 0.003) were independent predictors of baseline DWI lesions. A multivariate logistical model
predicting the presence of 1-month DWI lesions included history of any prior stroke (p ¼ 0.012), presence of 1 or more
microbleeds (p ¼ 0.04), black race (p ¼ 0.641), and presence of a DWI lesion at baseline (p ¼ 0.007).
Interpretation: This study demonstrates that >1=3 of patients with primary ICH have active cerebral ischemia at
baseline remote from the index hematoma, and 1=4 of patients experience ongoing, acute ischemic events at 1
month. Multivariate analyses implicate blood pressure reductions in the setting of an active vasculopathy as a
potential underlying mechanism. Further studies are needed to determine the impact of these lesions on outcome
and optimal management strategies to arrest vascular damage.
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Intracerebral hemorrhage (ICH) is a devastating disorderassociated with substantial morbidity and mortality.1
The often dismal outcome for patients with ICH high-
lights the need to better understand the underlying com-
plex pathophysiology of this disease process, which in
turn can assist in accurate determination of future stroke
risk, long-term outcome assessment, and perhaps most
importantly, development of treatment interventions.
Advanced magnetic resonance imaging (MRI) tech-
niques have become increasingly valuable in characteriz-
ing and refining our understanding of ICH pathophysiol-
ogy.2 In addition to demonstrating acute hemorrhage,
MRI can identify leukoaraiosis, chronic hematomas, and
microbleeds, thus providing insight into the etiology and
severity of the underlying disease process. Several recent
MRI studies have identified a high prevalence of topo-
graphically distant ischemic lesions identified on diffusion-
weighted imaging (DWI) in the setting of primary ICH.3–5
However, the underlying mechanism, time course, and sig-
nificance of these lesions is poorly understood.
This study seeks to determine the prevalence, char-
acteristics, risk factors, and temporal evolution of silent
ischemic lesions in a predominantly black, hypertensive
population of patients with primary ICH.
Patients and Methods
The current analysis was undertaken as part of an ongoing,
prospective, longitudinal MRI study of racial differences in pri-
mary ICH (DiffErenCes in the Imaging of Primary Hemor-
rhage based on Ethnicity or Race: DECIPHER). Since 2007,
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consecutive patients have been recruited from the inpatient serv-
ices of 5 Washington, DC metropolitan area hospitals. Inclusion
criteria are: age 18 years, diagnosis of primary ICH (not lim-
ited to first ICH), and brain MRI within 1 month of symptom
onset. Exclusion criteria are: contraindication to MRI, pregnancy,
central nervous system (CNS) tumor/active inflammatory pro-
cess, CNS arteriovenous malformation/aneurysm, CNS trauma
within prior 2 weeks, craniotomy, or international normalized
ratio >3. Baseline demographic information, medical history,
medications, neurologic assessments, and laboratory data are col-
lected on all patients. Blood pressure (BP) measurements are col-
lected for the following time points: admission, highest BP prior
to MRI, lowest BP prior to MRI, and 1 month. Differences in
mean arterial pressures (delta MAPs) are calculated for the vari-
ous time intervals. Results of cardiac evaluations including elec-
trocardiograms and echocardiograms are reviewed in combination
with cardiac history, such that each patient is categorized as hav-
ing a high-, low-, or no-risk cardioembolic source.
As part of the DECIPHER protocol, MRIs and outcome
assessments are performed at admission (baseline), 1 month, 1
year, and 3 years. Baseline MRIs are acquired on either 1.5T or
3.0Tmagnetic resonance (MR) scanners. All follow-up MR scans
are preferentially acquired on a 3.0T scanner. A standardized pro-
tocol is employed for all time points that includes DWI and
apparent diffusion coefficient (ADC), fluid attenuated inversion
recovery, and gradient recalled echo (GRE) sequences.
The DECIPHER study is being performed with approval
of the institutional review boards (IRBs) of the admitting hospitals
and Georgetown University, which serves as the IRB of record.
Imaging Analyses
For the current analysis, 3 investigators (R.S.M., R.E.B.,
C.S.K.) performed the imaging evaluations. An initial series of
15 cases were analyzed as consensus reads to establish inter-rater
reliability. All imaging analyses were performed using Mango
(Multi-Image Analysis GUI, http://ric.uthscsa.edu/mango/).
GRE sequences were evaluated for the following: hematoma
volume (using a semiautomated segmentation tool) and loca-
tion; number and location of microbleeds and chronic hemato-
mas; and presence of intraventricular hemorrhage (IVH).
Microbleeds were defined as rounded foci of hypointense signal
on GRE sequences within the brain parenchyma.6
DWI/ADC sequences were evaluated to characterize the
presence, number, location, volume, and acuity of ischemic
lesions topographically remote from the hematoma. DWI
hyperintensities immediately adjacent to the hematoma were
not included in this analysis. A comparison of equivalent axial
slices from the 2 time points was performed for each DWI
lesion visualized on the 1 month scan to determine (1) if it was
new (or persistent from the baseline time point); and (2) if
new, whether it was acute (low ADC value), or subacute (nor-
mal or elevated ADC value). Lateralized assessment of the to-
pography and severity of leukoaraiosis was assessed using the
Fazekas scale7 for periventricular (PV) and deep white matter
(DWM) regions. A sum score of white matter disease was cal-
culated as the sum of the PV and DWM scores.
Statistical Methods
Differences in dichotomous variables were analyzed using chi-
square analysis or the Fisher exact test. Student t test or the Wil-
coxon rank sum test was used to analyze differences in the mean
or median of continuous variables between groups. Variables that
indicated a univariate relationship with lesion presence (p < 0.1)
and were not strongly correlated with each other were considered
for multivariate logistic modeling. All statistical analyses were
performed using SAS version 9.2 (SAS Institute, Cary, NC).
Results
During the study time frame, 138 of 452 (31%) patients
meeting study eligibility criteria were enrolled. Of these, 119
subjects had a baseline MRI, 113 subjects had a 1-month
MRI, and 94 subjects had imaging at both baseline and
1-month time points. For the overall cohort, mean age was
59 years, 73% of patients were black, 54% were male, 84%
had a history of hypertension, and median National Insti-
tutes of Health Stroke Scale8 score was 5 (mean, 9). On
imaging, mean hematoma volume was 25ml (median, 14ml;
range, 0.4–136.4ml), and 74% of hematomas originated in
deep structures. The underlying etiology of the hemorrhage
was determined to be hypertension in 62% of patients, cere-
bral amyloid angiopathy in 1.5%, and unknown (no risk fac-
tors) in 3.6%, with the remainder due to hypertension plus
1 additional risk factors. Median time was 2 days to base-
line MRI and 35 days to 1-month MRI.
At the baseline time point, 35% of patients had 1
DWI lesions (median, 2; range, 1-67), for a total of 227
lesions in 42 of 119 patients. At the 1-month time point,
27% of patients had 1 DWI lesions (median, 2; range,
1–7), for a total of 67 lesions in 30 of 113 patients. Lesions
were generally small at both time points; median volume was
0.5ml (range, 0.04–16ml) for baseline lesions and 0.4ml
(range, 0.01–14ml) for 1-month lesions. Figure 1 provides an
example of a patient with multiple baseline DWI lesions, and
Figure 2 shows an example of a patient with a new acute
lesion visualized at 1 month and not present at baseline.
To clarify the evolution, acuity, and time course of
the ischemic lesions, an analysis was performed on the
subset of patients with MRIs at both baseline and
1-month time points. In this subset, there were 158 lesions
at baseline, and of these, 78% were identified as acute (low
ADC) and 22% as subacute (iso- or hyperintense ADC). At
1 month, there were a total of 40 lesions; of these, 58%
were acute and 42% were subacute. In total, 87% of
patients with lesions at 1 month had 1 new DWI lesions
compared to baseline, and 83% of all lesions at 1 month
were new compared to baseline. Of these new lesions, 64%
were acute and 36% were subacute.
Additional analyses were performed to further char-
acterize the topography and laterality of the DWI lesions.
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At baseline, 44% of the DWI lesions were located in lo-
bar locations, whereas at 1 month, only 13% were lobar.
At both the baseline and 1-month time points, approxi-
mately 1=3 of patients had DWI lesions ipsilateral to the
primary hematoma, 1=3 had contralateral lesions, and 1=3
had bilateral lesions (Fig 3).
Of the 138 patients, 49 (35.5%) patients had either
a transthoracic or transesophageal echocardiogram per-
formed. Only 9 patients were deemed to have a high-risk
cardioembolic source, and this did not differ significantly
between those with DWI lesions versus without (p ¼
0.179). Thirty-two patients (23%) had diagnostic cerebral
angiograms performed, with no difference in the frequency
of angiography between those with DWI lesions versus
those without (baseline, p ¼ 0.134; 1 month, p ¼ 0.325).
Univariate analyses were performed for baseline and 1
month, respectively, to identify differences in characteristics
for patients with 1 ischemic DWI lesions versus those with-
out. Table 1 shows the results for the baseline time point. In
contrast to patients without baseline lesions, patients with
lesions were significantly more likely to have a lobar ICH
(p ¼ 0.027), larger ICH volume (p ¼ 0.033), microbleeds
(p ¼ 0.015), IVH (p ¼ 0.002), and greater mean delta MAP
(p < 0.001), and were more likely to be treated with antihy-
pertensive agents during the acute hospital stay (p ¼ 0.031).
In multivariate logistical modeling, hematoma volume, IVH,
microbleeds, and delta MAP remained independent predic-
tors of the presence of baseline DWI lesions (Table 2).
Univariate analysis for the 1-month time point
(Table 3) demonstrated that patients with DWI lesions
had a greater likelihood of more severe leukoaraiosis
(p ¼ 0.004), microbleeds (p ¼ 0.004), chronic hemato-
mas (p ¼ 0.019), DWI lesions at baseline (p ¼ 0.001),
and greater mean delta MAP (p < 0.001). There was a
trend for DWI lesions to occur with greater frequency in
black patients (p ¼ 0.056) and in patients with prior
stroke history (p ¼ 0.056). A multivariate logistic regres-
sion model predicting the presence or absence of 1-month
DWI lesions was developed that included black race, his-
tory of any prior stroke, presence of 1 microbleeds, and
presence of a DWI lesion at baseline (Table 4). As mean
delta MAP was significantly correlated with baseline DWI
lesions, it was not incorporated into the 1-month model.
In this study with a primary focus on racial disparities in
FIGURE 2: Axial gradient recalled echo (GRE), diffusion-
weighted imaging (DWI), and apparent diffusion coefficient
(ADC) images from the 1-month time point in a 59-year-old
African American female. GRE sequence demonstrates a
subacute left periventricular hematoma and several deep
microbleeds. DWI image from a higher slice shows a hyper-
intense lesion in the right frontal lobe, and corresponding
ADC map shows hypointensity indicative of an acute event.
The lesion was not present on baseline imaging.
FIGURE 1: Serial axial magnetic resonance images of symp-
tomatic primary intracerebral hemorrhage (ICH) in a
69-year-old hypertensive white female. Top row shows the
gradient recalled echo (GRE) sequence demonstrating a left
parietofrontal primary ICH. Bottom row shows scattered
hyperintensities on diffusion-weighted imaging (DWI) at the
baseline time point remote from the primary ICH. A com-
plete workup for embolic stroke was negative.
FIGURE 3: Frequency of diffusion-weighted imaging ischemic
lesion laterality for the baseline and 1-month time points.
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a sample of predominantly black ICH patients, black race
was integrated into the model, given the significant associ-
ations with microbleeds and vascular risk factors.
Discussion
Summary of Findings
This prospective, longitudinal MRI-based study of pri-
mary ICH not only confirms prior studies reporting a
high frequency of ischemic lesions (topographically
remote from the hematoma) in the acute phase of pri-
mary ICH, but also extends these findings to provide
important new insights into the dynamic nature and
underlying etiology of these lesions. Our analysis identi-
fies active regions of remote ischemia at baseline in >1=3
of patients; follow-up imaging at 1 month demonstrates
ischemic lesions in >1=4. Notably, 83% of 1-month
lesions were new and not present on baseline imaging, a
finding indicative of an ongoing and active pathologic
process. Independent predictors of DWI lesions at baseline








Age, mean yr (SD) 59.8 (13.1) 60.9 (10.6) 59.1 (14.3) 0.445
Black race, No. [%] 87 [73.1] 32 [76.2] 54 [71.1] 0.575
Male gender, No. [%] 65 [54.6] 26 [61.9] 38 [50.0] 0.239
Hypertension, No. [%] 100 [84.0] 36 [85.7] 63 [82.9] 0.573
Delta MAP, mean mmHg (SD) 40.2 (24.1) 50.8 (25.0) 34.4 (21.7) <0.001
Acute in-hospital antihypertensive
treatment, No. [%]a
101 [88.6] 39 [97.5] 62 [83.8] 0.031
NIHSS, median {range} 5 {0–40} 7.5 {0–40} 4 {0–35} 0.136
Prior stroke, any type, No. [%] 33 [27.7] 15 [35.7] 18 [23.7] 0.151
High-risk CES, No. [%] 9 [7.6] 4 [9.5] 5 [6.5] 0.179
Lobar ICH, No. [%] 31 [26.1] 16 [38.1] 15 [19.7] 0.027
Pre-ICH antithrombotic use, No. [%]b 31 [26.1] 11 [26.2] 20 [27] 0.922
ICH volume, median ml {IQR} 13.9{0.4–136.4} 25.1 {0.6–109.9} 12.6 {0.4–136.4} 0.033
IVH, No. [%] 48 [40.3] 25 [59.5] 23 [30.3] 0.002
Microbleeds, No. [%] 69 [59.0] 31 [73.8] 38 [51.4] 0.015
Chronic hematomas, No. [%] 36 [30.5] 15 [35.7] 21 [28.0] 0.361
WMD score, median {range} 6 {0–12} 6 {2–12} 6 {0–12} 0.105
aIn-hospital antihypertensive use unavailable in 5 patients.
bBaseline antithrombotic use unavailable in 3 patients.
CES ¼ cardioembolic source; DWI ¼ diffusion-weighted imaging; ICH ¼ intracerebral hemorrhage; IQR ¼ interquartile range;
IVH ¼ intraventricular hemorrhage; MAP ¼ mean arterial pressure; NIHSS ¼ National Institute of Health Stroke Scale; SD ¼
standard deviation; WMD ¼ white matter damage.
TABLE 2: Multivariate Logistic Model for Presence of Baseline DWI Lesions
Factor Odds Ratio 95% CI p
Hematoma volume, ml 1.02 1.00 1.04 0.025
Baseline IVH 3.00 1.20 7.48 0.019
Baseline microbleeds 2.94 1.16 7.49 0.024
Delta MAP, mmHg 1.03 1.01 1.05 0.003
CI ¼ confidence interval; IVH ¼ intraventricular hemorrhage; MAP ¼ mean arterial pressure.
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included larger hematoma volume, intraventricular hemor-
rhage, microbleeds, and importantly, large reductions in
mean arterial BP. A multivariate model predicting ischemic
lesions at 1 month included presence of DWI lesions at
the baseline time point, prior stroke, microbleeds, and
black race.
Prior Literature
One prior study with a similar demographic profile to
that of our cohort evaluated 129 patients with MRI in
the first 28 days after acute primary ICH.3 DWI abnor-
malities were identified in 22.9% of patients and were asso-
ciated with prior stroke, mean arterial BP lowering, and
craniotomy. An analysis of microbleeds was not reported in
this study. In a separate study of patients with cerebral
amyloid angiopathy, 15% of patients demonstrated suba-
cute cerebral infarction on DWI studies.4 In this cohort,
DWI lesions were not associated with recent symptomatic
ICH, but were associated with higher microbleed burden.
Mechanisms and Pathophysiology
The etiology and underlying pathophysiology leading to
ischemic lesions remote from the index hematoma are
not yet well understood. Putative mechanisms include (1)
an active cerebral vasculopathy leading to contemporane-
ous vessel rupture and occlusion, (2) overly aggressive BP








Age, mean (SD) 58.3 (12.4) 58.8 (10.0) 58.0 (13.3) 0.751
Black race, No. [%] 83 [73.5] 26 [86.7] 57 [68.7] 0.056
Male gender, No. [%] 62 [54.9] 19 [63.3] 43 [51.8] 0.277
Hypertension, No. [%] 91 [80.5] 27 [90.0] 64 [77.1] 0.28
Delta MAP, mean mmHg (SD) 40.3 (26.0) 53.6 (25.6) 35.6 (24.5) < 0.001
NIHSS, median {range} 4 {0–40} 7 {0–40} 4 {0–40} 0.315
Prior stroke, any type, No. [%] 27 [23.9] 11 [36.7] 16 [19.3] 0.056
High-risk CES, No. [%] 7 [6.2] 2 [6.7] 5 [6.0] 0.999
Lobar ICH, No. [%] 22 [23.4] 6 [26.1] 16 [33.5] 0.727
ICH volume, median ml {IQR}a 12 {0.4–97.6} 12.7 {0.8–97.6} 11.2 {0.4–87.4} 0.667
IVH, No. [%]a 36 [38.3] 9 [39.1] 27 [38.0] 0.925
Microbleeds, No. [%]a 51 [55.4] 18 [81.8] 33 [47.1] 0.004
Chronic hematomas, No. [%] 30 [32.3] 12 [52.2] 18 [25.7] 0.019
WMD score, median {range} 6 {0–12} 8 {3–12} 6 {0–12} 0.004
Baseline DWI lesions, No. [%]a 30 [31.9] 14 [60.9] 16 [22.5] 0.001
aImaging data are based on the baseline imaging time point.
CES ¼ cardioembolic source; DWI ¼ diffusion-weighted imaging; ICH ¼ intracerebral hemorrhage; IQR ¼ interquartile range;
IVH ¼ intraventricular hemorrhage; MAP ¼ mean arterial pressure; NIHSS ¼ National Institute of Health Stroke Scale; SD ¼
standard deviation; WMD ¼ white matter damage.
TABLE 4: Multivariate Logistic Model for Presence of 1-Month DWI Lesions
Factor Odds Ratio 95% CI p
Any prior stroke 4.58 1.40 14.93 0.012
Baseline microbleeds 3.92 1.07 14.38 0.040
Baseline DWI lesions 4.72 1.53 14.63 0.007
Black vs nonblack race 1.37 0.36 5.18 0.641
CI ¼ confidence interval; DWI ¼ diffusion-weighted imaging.
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lowering in the acute (and possibly subacute) phase in the
setting of a diffuse angiopathy, and/or (3) an acute pro-
thrombotic/proinflammatory cascade triggered by the ini-
tial ICH or the underlying vasculopathic process itself.
Less likely causes include misidentification of hemorrhagic
conversion of embolic ischemic lesions (ie, misdiagnosis
of primary ICH), iatrogenically induced lesions related to
diagnostic angiography, or active vasculitis.
Our results strongly suggest an association between
DWI lesions in ICH and BP lowering during the acute
phase of ICH hospital stay. Historically, the foci of prior
studies of BP management in acute ICH have varied
based on the understanding of the underlying pathophys-
iology of ICH at the time. Initial theories regarding a pe-
numbra of perihematomal ischemia fostered a concern
for BP lowering and hypoperfusion in the acute phase.
This topic has been controversial; some studies have sug-
gested a transient zone of true ischemia in a subset of
patients, whereas others have not.9–11 Some advanced
imaging studies have additionally identified a perihemato-
mal penumbra of nonischemic, metabolically compro-
mised tissue.12 Most recent studies have focused upon the
association between early hematoma expansion, elevated
BP, and worsened clinical outcome. Two clinical trials
have demonstrated the relative safety of early BP lowering
with avoidance of substantial neurological deterioration
and adverse events, along with modest reductions in he-
matoma expansion.13,14 However, neither of these studies
integrated MRI assessments that might identify clinically
silent ischemia or microvascular damage.
BP lowering alone, however, may not be sufficient to
explain remote ischemia in the setting of acute ICH. We
postulate that an interaction may exist between BP lowering
and a severe underlying vasculopathy in the setting of ICH.
Results from our study and others suggest that imaging
and clinical markers of an underlying severe vasculopathy
(eg, prior stroke and microbleeds) are independent predic-
tors of ischemic lesions.3,4 Disease of the microvasculature,
whether due to hypertension or cerebral amyloid angiopa-
thy, has the potential to simultaneously lead to both ische-
mic and hemorrhagic insults sharing a common underly-
ing microangiopathic process. We hypothesize that the
development of ischemic lesions in acute and/or subacute
hypertensive ICH is caused by hemodynamic insufficiency
due to BP lowering in the setting of a diseased microvas-
culature that is unable to compensate due to autoregula-
tory failure. However, it is important to note that our
data only demonstrate an association between BP lowering
and DWI lesion presence, and further prospective studies
are needed not only to confirm this hypothesis, but also
to demonstrate that less aggressive BP treatment decreases
the rate of lesion development.
Significance
An understanding of the underlying mechanism(s) and
pathophysiology of ischemic lesions in the setting of
ICH has important implications for both prognosis and
treatment. Our study uniquely characterizes the fre-
quency of DWI lesions at 2 discrete time points (baseline
and 1 month). The presence of new ischemic lesions as
late as 1 month from ictus demonstrates the active nature
of this process. Although the delta MAP did not enter
into the 1-month predictive model, this was likely due to
colinearity with baseline DWI lesions, which in turn
were associated with the delta MAP. This finding suggests
that overaggressive BP reductions in the subacute phase
of ICH may have important implications. This popula-
tion of hypertensive patients, often with severe microvas-
cular disease, may have persistent loss of autoregulation.
Therefore, BP control within the normal range may not
be tolerated, and instead could induce hemodynamic
ischemia at the microvascular level.
Moreover, if BP lowering is the predominant factor
at either time point, it would be important to under-
stand the clinical significance of the DWI lesions (eg,
whether they are clinically silent or have a negative
impact on long-term functional outcome or cognitive sta-
tus). If BP control is associated with poorer outcome,
future studies exploring optimal BP control are needed
and should include MRI as an outcome marker. How-
ever, if ischemic lesions are thrombotic in nature and
triggered by the acute ICH and/or caused by an ongoing,
active vasculopathy at 1 month independent of BP, future
studies would be needed to explore the clinical signifi-
cance of the lesions, as well as optimal approaches to sec-
ondary prevention (eg, role of antiplatelet agents). Our
planned analysis of this population with a 1-year MRI
will allow us to characterize the frequency of DWI ische-
mic lesions at a time point far removed from the acute
hemorrhage (eg, chronic rate of lesion development in
this hypertensive ICH population).
Limitations
This study had some limitations. There is likely a selec-
tion bias toward milder hemorrhages with smaller vol-
umes, as patients with more severe hemorrhages may
have been too unstable for MRI. The sensitivity for
detection of microbleeds and ischemic DWI lesions may
depend on magnet strength. One prior report suggests
that 1.5T magnets may be more sensitive for detecting
hyperacute ischemia on diffusion-weighted imaging.15
Because the 1-month scans were preferentially acquired
on a 3.0T scanner, this may have decreased the overall
detection rate at this time point. We did not formally an-
alyze ischemic lesions based upon classical definitions of
ANNALS of Neurology
204 Volume 71, No. 2
watershed territories. However, it is unclear that diffuse
microvascular disease would have a watershed pattern
similar to large vessel disease. Finally, we did not rou-
tinely collect MR perfusion studies as part of our proto-
col. Future studies are needed to examine these issues.
Summary and Conclusions
In conclusion, we found that >1=3 of patients with ICH
have active cerebral ischemia topographically remote
from the acute hematoma at baseline, and importantly,
>1=4 of patients have imaging confirmation of active is-
chemia in the subacute phase of ICH. Multivariate analy-
ses implicate BP reductions in the setting of an active
vasculopathy as an underlying mechanism. Further stud-
ies are needed to determine the impact of these lesions
on outcome and optimal management strategies to arrest
vascular damage.
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